CIK 0000921114
- Non-accelerated filer
- Smaller reporting company
Armata Pharmaceuticals, Inc.
Sign in to watch- Ticker
- ARMP
- Exchange
- NYSE
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- WA
- Entity type
- Operating
- EIN
- 911549568
- Phone
- +1 310-665-2928
- Business address
- 5005 MCCONNELL AVE, LOS ANGELES, CA, 90066
- Former names
- AmpliPhi Biosciences Corp, TARGETED GENETICS CORP /WA/
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 22 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-03-14 | Kyme Pierre Chief Business Officer | Shares withheld for taxes | −1,030 | $10.54 | $11K | 9,461 |
| 2026-03-09 | Kyme Pierre Chief Business Officer | Grant or award · Stock Options (Right to Buy) | +183,142 | 183,142 | ||
| 2025-03-14 | Kyme Pierre Chief Business Officer | Shares withheld for taxes | −1,027 | $1.95 | $2K | 10,491 |
| 2025-02-05 | Kyme Pierre Chief Business Officer | Grant or award · Stock Options (Right to Buy) | +100,000 | 100,000 |
Page 1 of 1 · 4 trades